DECEMBER 2023LIFE SCIENCES REVIEW5CXO INSIGHTSLAST WORD182220242628Melanie Buitendyk, Director, Biostatistical Consulting,AllucentFabiana d'Aniello, PhD, R&D Portfolio Management Director, FerrerRivka Keakofsky, Associate Director, Market Insights and Strategy, BeiGeneNuala Trainor, Director of Innovation, LonzaInguna Adovica, Head of Clinical Research Quality Division, JSC Olainfarm, Vadims sis, Head of Medicine and Clinical Research Department,JSC OlainfarmKazuto yamada, Senior Director, Head of Clinical Development Planning and supervising five R&D functions, Otsuka Pharmaceutical co., LtdSherene Shakib Min, MD, MPH, VP, Head of Global Clinical Development, ViiV HealthcareThe Role of Statisticians in Study Design and Why to Engage Them EarlyDrug Development for Rare DiseasesDriving Success in the Dynamic Pharma IndustryMaking Cell Therapy Accessible to All PatientsRisk-based Approach in Vendor Assessment for Clinical Trials (CT) ServicesEvolving Digital Biomarkers in Clinical Trial SpaceClinical Trial Diversity in HIVIN MY OPINION08Clinical Trials Landscape in APAC and Its Unique Characteristics and OpportunitiesMarcia Matos, Clinical Operations HUB Director for APAC, Servier30
< Page 4 | Page 6 >